Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Aflibercept-based and Bevacizumab-based second line regim... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Aflibercept-based and Bevacizumab-based second line regimens in patients with metastatic colorectal cancer: propensity score weighted-analysis from a multicenter cohort.
0
Authors
Jessica Lucchetti
24 more
Jessica Lucchetti
•
Alessandro Minelli
22 more
•
Giuseppe Tonini
Published
January 1, 2025
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Clinical Colorectal Cancer
Topics
Medicine
Cancer Oncology
Internal Medicine
Surgery
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.clcc.2024.12.007
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Clinical Colorectal Cancer
Topics
Medicine
Cancer Oncology
Internal Medicine
Surgery
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.clcc.2024.12.007
License
CC-BY
